BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 14681886)

  • 1. Insertion of mutant proteolipid protein results in missorting of myelin proteins.
    Vaurs-Barriere C; Wong K; Weibel TD; Abu-Asab M; Weiss MD; Kaneski CR; Mixon TH; Bonavita S; Creveaux I; Heiss JD; Tsokos M; Goldin E; Quarles RH; Boespflug-Tanguy O; Schiffmann R
    Ann Neurol; 2003 Dec; 54(6):769-80. PubMed ID: 14681886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteolipid protein is necessary in peripheral as well as central myelin.
    Garbern JY; Cambi F; Tang XM; Sima AA; Vallat JM; Bosch EP; Lewis R; Shy M; Sohi J; Kraft G; Chen KL; Joshi I; Leonard DG; Johnson W; Raskind W; Dlouhy SR; Pratt V; Hodes ME; Bird T; Kamholz J
    Neuron; 1997 Jul; 19(1):205-18. PubMed ID: 9247276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assembly of CNS myelin in the absence of proteolipid protein.
    Klugmann M; Schwab MH; Pühlhofer A; Schneider A; Zimmermann F; Griffiths IR; Nave KA
    Neuron; 1997 Jan; 18(1):59-70. PubMed ID: 9010205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oligodendrocytes expressing exclusively the DM20 isoform of the proteolipid protein gene: myelination and development.
    Spörkel O; Uschkureit T; Büssow H; Stoffel W
    Glia; 2002 Jan; 37(1):19-30. PubMed ID: 11746780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myelin proteolipid proteins promote the interaction of oligodendrocytes and axons.
    Yool DA; Klugmann M; McLaughlin M; Vouyiouklis DA; Dimou L; Barrie JA; McCulloch MC; Nave KA; Griffiths IR
    J Neurosci Res; 2001 Jan; 63(2):151-64. PubMed ID: 11169625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolution of the myelin integral membrane proteins of the central nervous system.
    Schliess F; Stoffel W
    Biol Chem Hoppe Seyler; 1991 Sep; 372(9):865-74. PubMed ID: 1722981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genotype-phenotype correlation in inherited brain myelination defects due to proteolipid protein gene mutations. Clinical European Network on Brain Dysmyelinating Disease.
    Cailloux F; Gauthier-Barichard F; Mimault C; Isabelle V; Courtois V; Giraud G; Dastugue B; Boespflug-Tanguy O
    Eur J Hum Genet; 2000 Nov; 8(11):837-45. PubMed ID: 11093273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modification of Schwann cell phenotype with Plp transgenes: evidence that the PLP and DM20 isoproteins are targeted to different cellular domains.
    Anderson TJ; Montague P; Nadon N; Nave KA; Griffiths IR
    J Neurosci Res; 1997 Oct; 50(1):13-22. PubMed ID: 9379489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trafficking of PLP/DM20 and cAMP signaling in immortalized jimpy oligodendrocytes.
    Ghandour MS; Feutz AC; Jalabi W; Taleb O; Bessert D; Cypher M; Carlock L; Skoff RP
    Glia; 2002 Dec; 40(3):300-11. PubMed ID: 12420310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteolipid protein modulates preservation of peripheral axons and premature death when myelin protein zero is lacking.
    Patzig J; Kusch K; Fledrich R; Eichel MA; Lüders KA; Möbius W; Sereda MW; Nave KA; Martini R; Werner HB
    Glia; 2016 Jan; 64(1):155-74. PubMed ID: 26393339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Many naturally occurring mutations of myelin proteolipid protein impair its intracellular transport.
    Gow A; Friedrich VL; Lazzarini RA
    J Neurosci Res; 1994 Apr; 37(5):574-83. PubMed ID: 7518006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The early phenotype associated with the jimpy mutation of the proteolipid protein gene.
    Thomson CE; Anderson TJ; McCulloch MC; Dickinson P; Vouyiouklis DA; Griffiths IR
    J Neurocytol; 1999 Mar; 28(3):207-21. PubMed ID: 10617903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathomechanisms of mutant proteins in Charcot-Marie-Tooth disease.
    Niemann A; Berger P; Suter U
    Neuromolecular Med; 2006; 8(1-2):217-42. PubMed ID: 16775378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pathobiology of myelin mutants reveal novel biological functions of the MBP and PLP genes.
    Campagnoni AT; Skoff RP
    Brain Pathol; 2001 Jan; 11(1):74-91. PubMed ID: 11145205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disruption of the compacted myelin sheath of axons of the central nervous system in proteolipid protein-deficient mice.
    Boison D; Stoffel W
    Proc Natl Acad Sci U S A; 1994 Nov; 91(24):11709-13. PubMed ID: 7526402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PLP overexpression perturbs myelin protein composition and myelination in a mouse model of Pelizaeus-Merzbacher disease.
    Karim SA; Barrie JA; McCulloch MC; Montague P; Edgar JM; Kirkham D; Anderson TJ; Nave KA; Griffiths IR; McLaughlin M
    Glia; 2007 Mar; 55(4):341-51. PubMed ID: 17133418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for possible interactions between PLP and DM20 within the myelin sheath.
    McLaughlin M; Hunter DJ; Thomson CE; Yool D; Kirkham D; Freer AA; Griffiths IR
    Glia; 2002 Jul; 39(1):31-6. PubMed ID: 12112373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age-related axonal and myelin changes in the rumpshaker mutation of the Plp gene.
    Edgar JM; McLaughlin M; Barrie JA; McCulloch MC; Garbern J; Griffiths IR
    Acta Neuropathol; 2004 Apr; 107(4):331-5. PubMed ID: 14745569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotypic severity of murine Plp mutants reflects in vivo and in vitro variations in transport of PLP isoproteins.
    Thomson CE; Montague P; Jung M; Nave KA; Griffiths IR
    Glia; 1997 Aug; 20(4):322-32. PubMed ID: 9262236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of rumpshaker phenotype with wild-type PLP/DM20 suggests several pathogenic mechanisms.
    Barrie JA; Montague P; Karim S; Kirkham D; Nave KA; Anderson TJ; Griffiths IR; McLaughlin M
    J Neurosci Res; 2010 Aug; 88(10):2135-45. PubMed ID: 20175203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.